Bausch & Lomb Corp (BLCO) KPIs and segments

BLCONYSEOphthalmic GoodsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 9/3026% below fair value

$21.09−0.05 (-0.24%)

Close on Nov 13, 2026Market cap $7.54BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Bausch & Lomb's business

Bausch & Lomb's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023

Vision Care($M)6	774	784	711	778	736	753	656	723	684	697	635	662
Product sales($M)	773	781	708	775	734	751	654	721	682	695	633
OTC($M)	477	497	444	490	454	482	409	462	420	447	395	429
Devices($M)	285	270	253	270	270	258	235	247	250	237	229	222
Branded and Other Generics($M)	10	13	10	13	9	10	9	11	11	10	8	8
Other revenues($M)	1	3	3	3	2	2	2	2	2	2	2	2
Pharmaceuticals($M)	1	1	1	2	1	1	1	1	1	1	1	1
Pharmaceuticals($M)6	367	354	305	378	330	309	267	326	306	310	267	307
Product sales($M)	366	354	304	375	329	307	266	325	305	310	266
Pharmaceuticals($M)	318	299	265	317	279	259	221	267	246	244	208	262
Branded and Other Generics($M)	48	55	39	58	50	48	45	58	59	66	58	43
Other revenues($M)	1	0	1	3	1	2	1	1	1	0	1	2
Devices($M)	0	0	0	0	0	0	0	0	0	0	0	0
OTC($M)	0	0	0	0	0	0	0	0	0	0	0	0
Surgical($M)6	234	256	228	249	215	216	214	231	206	209	197	204
Devices($M)	232	254	227	248	214	214	213	229	205	208	195	203
Product sales($M)	232	254	227	248	214	214	213	229	205	208	195
Other revenues($M)	2	2	1	1	1	2	1	2	1	1	2	1
OTC($M)	0	0	0	0	0	0	0	0	0	0	0	0
Branded and Other Generics($M)	0	0	0	0	0	0	0	0	0	0	0	0
Pharmaceuticals($M)	0	0	0	0	0	0	0	0	0	0	0	0

Product sales($M)	1,371	1,389	1,239	1,398	1,277	1,272	1,133	1,275	1,192	1,213	1,094	1,168
Devices($M)	517	524	480	518	484	472	448	476	455	445	424	425
OTC($M)	477	497	444	490	454	482	409	462	420	447	395	429
Pharmaceuticals($M)	319	300	266	319	280	260	222	268	247	245	209	263
Branded and Other Generics($M)	58	68	49	71	59	58	54	69	70	76	66	51
Other revenues($M)	4	5	5	7	4	6	4	5	4	3	5	5

U.S. and Puerto Rico($M)								657	609	610	537	593
Other($M)								197	174	175	166	182
China($M)								96	92	93	77	94
France($M)								51	52	64	60	45
Japan($M)								50	45	43	42	48
United Kingdom($M)								35	33	33	31	32
Canada($M)								34	33	32	28	30
Germany($M)								32	38	40	42	32
Russia($M)								32	31	29	28	30
Spain($M)								26	20	25	21	23
Italy($M)								23	22	23	23	21
Mexico($M)								20	18	20	17	18
Poland($M)								15	17	18	15	14
South Korea($M)								12	12	11	12	11

Vision Care($M)	244	229	202	247	217	209	176	237	201	192	178	186
Pharmaceuticals($M)	134	89	66	134	76	37	11	56	69	78	53	74
Surgical($M)	32	17	9	15	8	2	-7	16	13	4	11	21

Vision Care2
Product sales($M)	492	490	437	482	455	461	403	454	430	437	408
Other revenues($M)	1	3	3	2	2	2	2	1	2	2	2
Surgical2
Product sales($M)	116	107	94	103	90	85	76	97	86	80	82
Other revenues($M)	2	2	1	1	1	2	1	2	1	1	2
Pharmaceuticals2
Product sales($M)	278	265	226	281	223	203	173	225	212	214	181
Other revenues($M)	0	0	0	3	0	0	0	0	1	-1	0

Product sales($M)	886	862	757	866	768	749	652	776	728	731	671	707
Other revenues($M)	3	5	4	6	3	4	3	3	4	2	4	5

9 metrics have no data in the last 12 quarters — .

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics

Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-10-28.

See a number that looks wrong?